Figure 3. Improvement of intermediate uveitis after 2 weeks’ discontinuation of Rifabutin

From

Rifabutin low dose-induced intermediate uveitis in a patient with Acquired Immunodeficiency Syndrome

Agustina C. Palacio, Mercedes Cabrini, Graciela Ben, Emilio M. Dodds

American Journal of Medical Case Reports. 2017, 5(5), 116-118 doi:10.12691/ajmcr-5-5-3